| # | Drug | Count |
|---|---|---|
| 0 | VALSARTAN | 87 |
| 1 | VALSARTAN ORAL | 86 |
| 2 | FOLIC ACID | 73 |
| 3 | FUROSEMIDE | 67 |
| 4 | INSULIN GLARGINE | 58 |
| 5 | RAMIPRIL | 57 |
| 6 | INSULIN LISPRO | 56 |
| 7 | METHYLDOPA | 55 |
| 8 | METFORMIN | 54 |
| 9 | NICARDIPINE | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORPROMAZINE HYDROCHLORIDE | 24 | 0.0252 |
| 1 | NICARDIPINE HYDROCHLORIDE | 41 | 0.0183 |
| 2 | NICARDIPINE | 53 | 0.0120 |
| 3 | METHYLDOPA | 55 | 0.0111 |
| 4 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 5 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 6 | CHLORPROMAZINE | 23 | 0.0037 |
| 7 | LABETALOL | 45 | 0.0033 |
| 8 | PROPYLTHIOURACIL | 6 | 0.0029 |
| 9 | METEX | 1 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 96 |
| 1 | Vitamin B12 [EPC] | 73 |
| 2 | Vitamin C [EPC] | 73 |
| 3 | Vitamin D [EPC] | 73 |
| 4 | Insulin Analog [EPC] | 67 |
| 5 | Loop Diuretic [EPC] | 67 |
| 6 | Atypical Antipsychotic [EPC] | 63 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 57 |
| 8 | beta-Adrenergic Blocker [EPC] | 52 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 47 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 7 | 0.0007 |
| 1 | Cholinergic Nicotinic Agonist [EPC] | 32 | 0.0005 |
| 2 | Angiotensin Converting Enzyme Inhibitor [EPC] | 57 | 0.0004 |
| 3 | Protease Inhibitor [EPC] | 18 | 0.0004 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 96 | 0.0003 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 18 | 0.0003 |
| 8 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |